Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00505167
What this trial is testing

Memantine Versus Donepezil in Early Stages of Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
Hospital Miguel Servet 64
Not applicableStudy completedNCT05669365
What this trial is testing

The Care Ecosystem Consortium Effectiveness Study

Who this might be right for
DementiaDementia, VascularDementia With Lewy Bodies+2 more
University of California, San Francisco 1,227
Not applicableLooking for participantsNCT06618872
What this trial is testing

Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment

Who this might be right for
DementiaAlzheimer Disease
University Hospital, Geneva 120
Early research (Phase 1)Study completedNCT02782975
What this trial is testing

Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants

Who this might be right for
Alzheimer's Disease
Biogen 28
Large-scale testing (Phase 3)Ended earlyNCT03114657
What this trial is testing

Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 806
Not applicableUnknownNCT03330353
What this trial is testing

Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy

Who this might be right for
PSP - Progressive Supranuclear PalsyPD - Parkinson's DiseaseAD - Alzheimer's Disease+1 more
Massachusetts General Hospital 56
Early research (Phase 1)Not Yet RecruitingNCT07768592
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimers Disease
Eisai Inc. 32
Not applicableUnknownNCT02802371
What this trial is testing

Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program

Who this might be right for
Alzheimer Disease
Hospices Civils de Lyon 240
Not applicableStudy completedNCT02912936
What this trial is testing

A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease

Who this might be right for
Alzheimer's DiseasePrimary Progressive Non-fluent AphasiaFrontotemporal Dementia (FTD)
University of British Columbia 43
Not applicableUnknownNCT02623764
What this trial is testing

EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors

Who this might be right for
Alzheimer´s Disease
Landspitali University Hospital 218
Not applicableNot Yet RecruitingNCT05987007
What this trial is testing

Sleep Interventions and Neurocognitive Outcomes

Who this might be right for
Sleep DisturbanceAmnestic Mild Cognitive Impairment
New York State Psychiatric Institute 50
Not applicableStudy completedNCT05544201
What this trial is testing

Transcranial Alternating Current Stimulation (TACS) for Sleep Disturbances in Neurocognitive Disorders Due to Alzheimer's Disease

Who this might be right for
Brain StimulationAlzheimer DiseasetACS+3 more
Chinese University of Hong Kong 99
Large-scale testing (Phase 3)Study completedNCT00095719
What this trial is testing

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Who this might be right for
DementiaAlzheimer's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 125
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800
Not applicableLooking for participantsNCT07118137
What this trial is testing

Memory Deterioration in Alzheimer Disease

Who this might be right for
Alzheimer DiseaseNeurodegenerative DiseasesMagnetic Resonance Imaging+1 more
Norwegian University of Science and Technology 30
Very early researchStudy completedNCT04200911
What this trial is testing

Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway

Who this might be right for
Cognitive Impairment, MildAlzheimer Disease
The University of Texas Health Science Center at San Antonio 10
Not applicableNot Yet RecruitingNCT07214194
What this trial is testing

Vagus Nerve Stimulation to Enhance Memory in Aging

Who this might be right for
Alzheimer DiseaseAging
Stanford University 150
Early research (Phase 1)Study completedNCT01548430
What this trial is testing

A Safety Study of TTP4000 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
vTv Therapeutics 8
Early research (Phase 1)Study completedNCT01859767
What this trial is testing

Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs.

Who this might be right for
Alzheimer's Disease
Molecular NeuroImaging 6
Large-scale testing (Phase 3)Looking for participantsNCT07724132
What this trial is testing

An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer Disease Dementia
University College, London 1,200
Next Page